0.34
price up icon0.00%   0.00
after-market 시간 외 거래: .33 -0.01 -2.94%
loading

Aptevo Therapeutics Inc (APVO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Research and Development
4.48%
3.752
3.591 3.887 5.462 4.168
Operating Income/Loss
9.38%
-6.983
-6.384 -6.561 -8.178 -7.756
Income/Loss From Continuing Operations Before Tax
10.30%
-6.834
-6.196 -6.334 -7.948 2.773
Income/Loss From Continuing Operations After Tax
10.30%
-6.834
-6.196 -6.334 -7.948 1.827
Income/Loss From Discontinued Operations, Net Of Tax
100.00%
-
0.293 - - 0.946
Net Income/Loss
15.77%
-6.834
-5.903 -6.334 -7.948 2.773
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Diluted Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Basic Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Diluted Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$65.71
price down icon 3.01%
$19.31
price down icon 3.11%
$32.82
price down icon 1.59%
$24.61
price down icon 2.57%
$94.50
price down icon 2.85%
biotechnology ONC
$224.73
price down icon 3.65%
자본화:     |  볼륨(24시간):